套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-22-105728 Act: 34 Size: 98 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-010256 Size: 11 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-014796 Size: 21 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-014794 Size: 12 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-014737 Size: 4 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-22-104425 Act: 34 Size: 1 MB 网页链接
$Lyra Therapeutics(LYRA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001564590-22-009351 Act: 33 Size: 259 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-22-009187 Act: 34 Size: 10 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-009185 Act: 34 Size: 418 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-22-009915 Size: 7 KB 网页链接